Differentiation of monocytes to macrophages switches the Mycobacterium tuberculosis effect on HIV-1 replication from stimulation to inhibition: Modulation of interferon response and CCAAT/enhancer binding protein β expression

Journal of Immunology

Volumn 165, Issue 4, 2000, Pages 2028-2039

  Weiden, M ^a   Tanaka, N ^a   Qiao, Y ^a   Zhao, B Y ^a   Honda, Y ^a   Nakata, K ^a   Canova, A ^a   Levy, D E ^a   Rom, W N ^a   Pine, R ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ENHANCER REGION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; INFECTION RISK; MACROPHAGE; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TUBERCULOSIS; VIRUS REPLICATION;

EID: 0034663956     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.4.2028     Document Type: Article

References (71)

1. Persistence of HIV-1 transcription in peripheral blood mononuclear cells in patients receiving potent antiretroviral therapy
2. Quantifying residual HIV-1 replication in patients-receiving combination antiretroviral therapy
3. Low copy number and limited variability of proviral DNA in alveolar macrophages from HIV-1 infected patients: Evidence for genetic differences in HIV-1 between lung and blood macrophage populations
4. M. tuberculosis enhances human immunodeficiency virus-1 replication in the lung
5. Macrophages as a source of HIV during opportunistic infections
6. C/EBP proteins activate transcription from human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes
7. Mycobacterium tuberculosis enhances HIV-1 replication by transcriptional activation at the long terminal repeat
8. Transactivation of human immunodeficiency virus type 1 long terminal repeats by cell surface tumor necrosis factor α
9. Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficient virus type-1 expression
10. Tumor necrosis factor α activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NFκB sites in the long terminal repeat
11. Infection of human monocytes with Mycobacterium tuberculosis enhances human immunodeficiency virus type 1 replication and transmission to T cells
12. The in vitro induction of human immunodeficiency virus (HIV) replication in purified protein derivative-positive HIV-infected persons by recall antigen response to Mycobacterium tuberculosis is the result of a balance of the effects of endogenous inlerleukin-2 and proinflammatory and antiinflammatory cytokines
13. IFNs and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro
14. Enhanced production of LPS-induced cytokines during differentiation of human monocytes to macrophages: Role of LPS receptors
15. Type I interferon induces inhibitory 16 kDa C/EBP-β repressing the HIV-1 LTR in Macrophages: Pulmonary tuberculosis alters C/EBP expression enhancing HIV-1 replication
16. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferon α and β and alters macrophage responses
17. Endogenous interferon-α/β suppresses colony-stimulating factor (CSF- 1) stimulated macrophage DNA synthesis and mediates inhibitory effects of LPS and TNF-α
18. A nuclear factor for IL-6 expression (NF-IL6)
19. Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin 6
20. C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines
21. + T cells
22. Activation of human monocyte-derived macrophages with lipopolysaccharide decreases human immunodeficiency virus replication at the level of gene expression
23. NF IL-6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1
24. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA
25. CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials
26. Evidence for posttranscriptional regulation of C/EBPα and C/EBPβ isoform expression during lipopolysaccharide-mediated acute-phase response
27. Autocrine signals control CCAAT/enhancer binding protein β expression, localization and activity in macrophages
28. C/EBPα regulates generation of C/EBPβ isoforms through activation of specific proteolytic cleavage
29. Interferons and their actions
30. Immune defense in mice lacking type I and/or type II interferon receptors
31. The interferon-α/β responses of mice to herpes simplex virus studied at the blood and tissue level in vitro and in vivo
32. Innate immunity: The virtues of a nonclonal system of recognition
33. STATs and gene regulation
34. The human interferon α/β receptor: Characterization and molecular cloning
35. Functional role of type I and type II interferons in antiviral defense
36. Combinatorial association and abundance of interferon stimulated gene factor 3 components dictate the selectivity of interferon responses
37. The STAT family of proteins in cytokine signaling
38. The response of γ interferon activation factor is under development control in cells of the macrophage lineage
39. Retinoic acid induces signal transducer and activator of transcription (STAT) 1, STAT 2, and p48 expression in myeloid leukemia cells and enhances their responsiveness to interferons
40. Differential regulation of the α/β interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1
41. Requirement for MAP kinase (ERK2) activity in interferon α- and interferon β-stimulated gene expression through STAT proteins
42. The SH2 domain-containing tyrosine phosphatase PTPID is required for interferon α/β-induced gene expression
43. Inhibition of Stat1-mediated gene activation by PIASI
44. Interferon induction of TAP1: The phosphatase SHP-1 regulates crossover between the IFN-α/β and the IFN-γ signal-transduction pathways
45. A Janus kinase inhibitor, JAB, is an interferon-γ-inducible gene and confers resistance to interferons
46. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities
47. Negative regulation of the JAK/STAT pathway
48. The distribution of immunoreactive interferon-α in normal human tissues
49. Constitutive expression of an ISGF2/IRF1 transgene leads to interferon-independent activation of interferon-inducible genes and resistance to virus infection
50. Isolation of intact nuclei for nuclear extract preparation from a fragile B-lymphocyte cell line
51. Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFNα and IFNγ and is likely to autoregulate the p91 gene
52. Purification and cloning of interferon-stimulated-gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both interferon-β and interferon-stimulated genes but is not a primary transcriptional activator of either
53. Activation of infectious virus from latent human immunodeficiency virus infection of monocytes in vivo
54. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
55. Ras regulates the association of serum response factor and CCAAT/enhancer-binding protein β
56. Activation induced resistance of human macrophages to HIV-1 in vitro
57. Mechanisms for the inhibition of HIV replication by interferons-α, - β, and -γ in primary human macrophages
58. Regulation of HIV-1 replication in infected monocytes by IFN-α: Mechanism for viral restriction
59. Synergistic interaction between interferon-α and interferon-γ through induced synthesis of one subunit of the transcription factor ISGF-3
60. Interferon-γ potentiates the antiviral response and transcriptional activation induced by interferon-α in U937 cells
61. Restoration of interferon responses of adenovirus E1A-expressing HT1080 cell lines by overexpression of p48 protein
62. The IRF pathway operates distinctively from the Stat pathway in hematopoietic cells and transduces common and distinct signals during engagement of the insulin or intefferon-α receptors
63. Role of STAT2 in the alpha interferon signaling pathway
64. Function of Stat2 protein in transcriptional activation by alpha interferon
65. Functional subdomains of STAT2 required for preassociation with the α interferon receptor and for signaling
66. Identification of the rel family members required for induction of the human β-interferon gene
67. Activation of the interleukin-6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by NF-IL6 and NFκB
68. C/EBPβ regulation of the tumor necrosis factor α gene
69. Lymphoproliferative disorder and imbalanced T-helper response in C/EBP-β-deficient mice
70. Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBPβ-deficient mice
71. Effects of aerosolized interferon-α in patients with pulmonary tuberculosis